- Home
- XFOR vs KRMD Comparison
XFOR vs KRMD Comparison
Compare XFOR & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- KRMD
- Stock Information
- Founded
- XFOR 2014
- KRMD 1980
- Country
- XFOR United States
- KRMD United States
- Employees
- XFOR N/A
- KRMD N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- KRMD Medical/Dental Instruments
- Sector
- XFOR Health Care
- KRMD Health Care
- Exchange
- XFOR Nasdaq
- KRMD Nasdaq
- Market Cap
- XFOR 118.4M
- KRMD 134.3M
- IPO Year
- XFOR N/A
- KRMD N/A
- Fundamental
- Price
- XFOR $1.61
- KRMD $3.28
- Analyst Decision
- XFOR Strong Buy
- KRMD Strong Buy
- Analyst Count
- XFOR 3
- KRMD 4
- Target Price
- XFOR $72.33
- KRMD $4.63
- AVG Volume (30 Days)
- XFOR 1.8M
- KRMD 120.6K
- Earning Date
- XFOR 08-11-2025
- KRMD 08-06-2025
- Dividend Yield
- XFOR N/A
- KRMD N/A
- EPS Growth
- XFOR N/A
- KRMD N/A
- EPS
- XFOR 2.16
- KRMD N/A
- Revenue
- XFOR $31,364,000.00
- KRMD $35,083,740.00
- Revenue This Year
- XFOR $1,300.08
- KRMD $18.16
- Revenue Next Year
- XFOR N/A
- KRMD $14.60
- P/E Ratio
- XFOR $0.74
- KRMD N/A
- Revenue Growth
- XFOR N/A
- KRMD 19.65
- 52 Week Low
- XFOR $1.38
- KRMD $1.86
- 52 Week High
- XFOR $26.83
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- XFOR 40.77
- KRMD 44.31
- Support Level
- XFOR $1.55
- KRMD $3.34
- Resistance Level
- XFOR $2.22
- KRMD $3.61
- Average True Range (ATR)
- XFOR 0.20
- KRMD 0.17
- MACD
- XFOR 0.06
- KRMD -0.02
- Stochastic Oscillator
- XFOR 26.44
- KRMD 35.71
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).